Showing results (61-70 of 332) with videos related to
Sort By:
Pageof 34
Anti-Cancer Drugs|April 11, 2000
Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three casesA Brandes, U Reichmann, L Plasswilm, et al.International Journal of Oral and Maxillofacial Surgery|December 1, 1994
Experimental improvement of microvascular allografts with the new material polyurethane and microvessel endothelial cell seedingR Bschorer, G B Köveker, G Gehrke, et al.Journal of Neuro-Oncology|August 6, 2002
Non-cytotoxic therapies for malignant gliomasUmberto Basso, Mario Ermani, Francesca Vastola, et al.Seminars in Oncology|February 7, 2004
The European Organisation for Research and Treatment of Cancer strategy for new drug development in brain tumorsDenis Lacombe, Alba A Brandes, Martin van den BentForum (Genoa, Italy)|January 21, 2004
Guidelines for the treatment of malignant gliomas in elderly patientsU Basso, A Tosoni, F Vastola, et al.European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|November 1, 1993
Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytesE Wieland, A Brandes, V W Armstrong, et al.Expert Opinion on Investigational Drugs|July 12, 2005
Novel therapeutics in adult malignant brain gliomasMichele Reni, Elena Mazza, Alicia Tosoni, et al.Critical Reviews in Oncology/Hematology|October 10, 2006
Glioblastoma in the elderly: current and future trendsAlba A Brandes, Alessia Compostella, Valeria Blatt, et al.Astrobiology|February 5, 2009
Inorganic nitrogen reduction and stability under simulated hydrothermal conditionsJay A Brandes, Robert M Hazen, Hatten S YoderExpert Review of Anticancer Therapy|November 6, 2008
Association between response to primary treatments and MGMT status in glioblastomaEnrico Franceschi, Alicia Tosoni, Eugenio Pozzati, et al.Pageof 34